A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Clinical trial NCT02941991 · COMPLETED
Trial details
- NCT number
- NCT02941991
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-16
- Primary completion
- 2019-10-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.